66733-0948
                        
                    
                            Erbitux
                        
                    
                                    Cetuximab
                                
                            
                        
                    
                            Solution
                        
                    
                                    Intravenous
                                
                            
                        
                    
                                     Cetuximab
                                
                                
                                     2.0
                                
                                
                                     mg/mL
                                
                                
                            
                        
                    
                                     66733-0948-23
                                
                                
                                     1 VIAL, SINGLE-DOSE in 1 CARTON (66733-948-23)  / 50 mL in 1 VIAL, SINGLE-DOSE
                                
                                
                                     Feb. 12, 2004
                                
                                
                                    Immunotherapy
                                
                            
                        
                    
                                    Monoclonal Antibody
                                
                            
                        
                    
                                    EGFR
                                
                            
                        
                    
                            In Use
                        
                     An official website of the United States government
 An official website of the United States government
		 Home
 Home 
                             
                    